Author details

Full Name

Zivana Tezak

Affiliation

Center for Devices and Radiological Health

ORCID

Career Start Year

1992

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37265412	FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.	Clin Cancer Res	2023
37265412	FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.	Clin Cancer Res	2023
34036290	A community effort to identify and correct mislabeled samples in proteogenomic studies.	Patterns (N Y)	2021
34036290	A community effort to identify and correct mislabeled samples in proteogenomic studies.	Patterns (N Y)	2021
34504347	Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.	Nat Biotechnol	2021
34504346	Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.	Nat Biotechnol	2021
34504347	Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.	Nat Biotechnol	2021
34504346	Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.	Nat Biotechnol	2021
30858580	Best practices for benchmarking germline small-variant calls in human genomes.	Nat Biotechnol	2019
30858580	Best practices for benchmarking germline small-variant calls in human genomes.	Nat Biotechnol	2019
30899106	Author Correction: Best practices for benchmarking germline small-variant calls in human genomes.	Nat Biotechnol	2019
30899106	Author Correction: Best practices for benchmarking germline small-variant calls in human genomes.	Nat Biotechnol	2019
30194412	Right data for right patient-a precisionFDA NCI-CPTAC Multi-omics Mislabeling Challenge.	Nat Med	2018
30194412	Right data for right patient-a precisionFDA NCI-CPTAC Multi-omics Mislabeling Challenge.	Nat Med	2018
28315672	Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical Settings.	J Mol Diagn	2017
28315672	Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical Settings.	J Mol Diagn	2017
27099173	A research roadmap for next-generation sequencing informatics.	Sci Transl Med	2016
27099173	A research roadmap for next-generation sequencing informatics.	Sci Transl Med	2016
25370936	The first FDA marketing authorizations of next-generation sequencing technology and tests: challenges, solutions and impact for future assays.	Expert Rev Mol Diagn	2015
25370936	The first FDA marketing authorizations of next-generation sequencing technology and tests: challenges, solutions and impact for future assays.	Expert Rev Mol Diagn	2015
24063748	Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.	J Proteome Res	2013
24063748	Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.	J Proteome Res	2013
22655855	Characterization of whole genome amplified (WGA) DNA for use in genotyping assay development.	BMC Genomics	2012
22655855	Characterization of whole genome amplified (WGA) DNA for use in genotyping assay development.	BMC Genomics	2012
21300740	The journey to regulation of protein-based multiplex quantitative assays.	Clin Chem	2011
21300740	The journey to regulation of protein-based multiplex quantitative assays.	Clin Chem	2011
21885623	Direct-to-consumer genetic testing: reliable or risky?	Clin Chem	2011
21856459	Regulatory perspective on translating proteomic biomarkers to clinical diagnostics.	J Proteomics	2011
21856459	Regulatory perspective on translating proteomic biomarkers to clinical diagnostics.	J Proteomics	2011
21885623	Direct-to-consumer genetic testing: reliable or risky?	Clin Chem	2011
20007858	Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration.	Clin Chem	2010
29776248	US FDA and personalized medicine: in vitro diagnostic regulatory perspective.	Per Med	2010
22833953	Biomarkers to improve the benefit/risk balance for approved therapeutics: a US FDA perspective on personalized medicine.	Ther Deliv	2010
20676074	The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.	Nat Biotechnol	2010
20007859	Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.	Clin Chem	2010
20007858	Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration.	Clin Chem	2010
29776248	US FDA and personalized medicine: in vitro diagnostic regulatory perspective.	Per Med	2010
22833953	Biomarkers to improve the benefit/risk balance for approved therapeutics: a US FDA perspective on personalized medicine.	Ther Deliv	2010
20676074	The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.	Nat Biotechnol	2010
20007859	Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.	Clin Chem	2010
24980716	Biomarkers for pharmacogenetic and pharmacogenomic studies: Locking down analytical performance.	Drug Discov Today Technol	2007
24980717	Biomarkers for pharmacogenetic and pharmacogenomic studies: special issues in analytical performance.	Drug Discov Today Technol	2007
24980716	Biomarkers for pharmacogenetic and pharmacogenomic studies: Locking down analytical performance.	Drug Discov Today Technol	2007
24980717	Biomarkers for pharmacogenetic and pharmacogenomic studies: special issues in analytical performance.	Drug Discov Today Technol	2007
16460648	FDA perspectives on potential microarray-based clinical diagnostics.	Hum Genomics	2006
16964229	The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.	Nat Biotechnol	2006
16460648	FDA perspectives on potential microarray-based clinical diagnostics.	Hum Genomics	2006
16402088	Designing prospective clinical pharmacogenomic (PG) trials: meeting report on drug development strategies to enhance therapeutic decision making.	Pharmacogenomics J	2006
16964229	The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.	Nat Biotechnol	2006
16402088	Designing prospective clinical pharmacogenomic (PG) trials: meeting report on drug development strategies to enhance therapeutic decision making.	Pharmacogenomics J	2006

1 - 50 of 60

John F K Sauld

Emulate Inc.

Career Start Year 2013

Number of shared co-authors 0

Kristy Lee

The University of North Carolina at Chapel Hill

Career Start Year 2009

Number of shared co-authors 3

Elisa Pin

KTH Royal Institute of Technology

Career Start Year 2007

Number of shared co-authors 0

John R Mills

Mayo Clinic

Career Start Year 2007

Number of shared co-authors 0

Ioannis Prassas

Mount Sinai Hospital

Career Start Year 2007

Number of shared co-authors 1

Eric W Klee

Mayo Clinic College of Medicine and Science

Career Start Year 2001

Number of shared co-authors 5

Stella Somiari

Windber Research Institute

Career Start Year 2000

Number of shared co-authors 1

Kerby Shedden

University of Michigan ann arbor

Career Start Year 1999

Number of shared co-authors 0

Linnea M Baudhuin

Mayo Clinic

Career Start Year 1999

Number of shared co-authors 2

??kos V??gv??ri

Karolinska Institutet

Career Start Year 1998

Number of shared co-authors 1

Lawrence J Jennings

Northwestern University Feinberg School of Medicine

Career Start Year 1998

Number of shared co-authors 2

Patricia Porter-Gill

Arkansas Children's Research Institute

Career Start Year 1998

Number of shared co-authors 0

Wenzhong Xiao

Stanford University

Career Start Year 1997

Number of shared co-authors 22

Cristina Al-Khalili Szigyarto

KTH-Royal Institute of Technology

Career Start Year 1995

Number of shared co-authors 0

Wim Van Criekinge

Ghent University

Career Start Year 1995

Number of shared co-authors 2

Gary Hardiman

Institute for Global Food Security, Queen's University Belfast

Career Start Year 1994

Number of shared co-authors 2

Joni L Rutter

National Center for Advancing Translational Sciences

Career Start Year 1993

Number of shared co-authors 4

Gregory J Tsongalis

Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine

Career Start Year 1990

Number of shared co-authors 1

Richard D Press

Oregon Health and Science University

Career Start Year 1988

Number of shared co-authors 1

Johan Lindberg

Karolinska Institute

Career Start Year 1988

Number of shared co-authors 2

Philip J R Day

University of Cape Town

Career Start Year 1988

Number of shared co-authors 0

Karen E Weck

University of North Carolina at Chapel Hill

Career Start Year 1987

Number of shared co-authors 6

Hanna Rennert

New York NewYork-Presbyterian Hospital

Career Start Year 1986

Number of shared co-authors 4

Gy??rgy Marko-Varga

Clinical Protein Science & Imaging, Biomedical Centre, Lund University

Career Start Year 1984

Number of shared co-authors 3

David M Rocke

University of California davis

Career Start Year 1983

Number of shared co-authors 0

Geoffrey S Ginsburg

National Institutes of Health

Career Start Year 1981

Number of shared co-authors 4

Wayne W Grody

David Geffen School of Medicine, university of california los angeles

Career Start Year 1980

Number of shared co-authors 6

Peter Nilsson

Linkoping University

Career Start Year 1978

Number of shared co-authors 1

Carolyn Sue Richards

Oregon Health & Science University (OHSU)

Career Start Year 1978

Number of shared co-authors 7

Gilbert S Omenn

and School of Public Health, University of Michigan ann arbor

Career Start Year 1965

Number of shared co-authors 8

row(s) 1 - 30 of 30

Elizabeth Mansfield

Co-authored papers 10

Henry Rodriguez

Office of Cancer Clinical Proteomics Research, National Cancer Institute

Co-authored papers 6

Roderick V Jensen

Virginia Tech

Co-authored papers 4

Christopher E Mason

Feil Family Brain and Mind Research Institute.

Co-authored papers 4

Reena Philip

Center for Devices and Radiological Health

Co-authored papers 4

Emily S Boja

Office of Cancer Clinical Proteomics Research, National Cancer Institute

Co-authored papers 4

Baitang Ning

Co-authored papers 4

N L Anderson

Co-authored papers 4

Huixiao Hong

Co-authored papers 4

Justin M Zook

National Institute of Standards and Technology

Co-authored papers 4

Ming Shi

Co-authored papers 4

Charles Wang

Co-authored papers 4

Marina V Kondratovich

Co-authored papers 4

Weida Tong

National Center for Toxicological Research

Co-authored papers 4

Wendell D Jones

Department of Bioinformatics and Clinical Systems

Co-authored papers 3

Marc Salit

Stanford University

Co-authored papers 3

Steven J Skates

Co-authored papers 3

James C Fuscoe

Co-authored papers 3

Christopher R Kinsinger

Co-authored papers 3

Mehdi Mesri

Co-authored papers 3

Rebecca Truty

Invitae Corporation

Co-authored papers 3

James C Willey

Co-authored papers 3

David F Ransohoff

Co-authored papers 3

Daniel C Liebler

Co-authored papers 3

Gary P Schroth

Co-authored papers 3

Andreas Scherer

Institute for Molecular Medicine Finland (FIMM), University of Helsinki

Co-authored papers 3

Kellie Kelm

Co-authored papers 3

Steven A Carr

Broad Institute of MIT and Harvard

Co-authored papers 3

George Asimenos

Co-authored papers 3

Chunlin Xiao

Chongqing Aier Eye Hospital

Co-authored papers 3

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators